We are reimagining eyecare with transformative technology and an interventional mindset. We believe interventions should happen sooner to preserve, protect, or restore natural eye function. So, we aim to provide eyecare providers with transformative, clinically-proven therapies that are intuitive, less invasive, and more intelligent.
External link for Sight Sciences
4040 Campbell Ave
Suite 100
Menlo Park, California 94025, US
From all of us at Sight Sciences, Happy Thanksgiving! We are grateful for our amazing team and their dedication every day. This holiday, we are celebrating with good food, great company, fun activities, and heartfelt gratitude. Wishing everyone a Thanksgiving filled with warmth, joy, and cherished moments with loved ones!
Thank you to the 18 delegates who joined us in Düsseldorf on Saturday for an engaging OMNI Surgical System Masterclass! Led by the brilliant Dr. Karsten Klabe, the day was packed with hands-on learning and insightful discussions. From clinical presentations and dynamic roundtables to dedicated dry-lab training, attendees gained valuable skills to elevate their practice. A special thanks to the Sight Sciences Germany team for supporting such a successful event! Interested in joining our future sessions? Contact us at eventsDE@sightsciences.com—we’d love to see you there.
Join us in welcoming Reggie Mapson and Erik Trevino to the Ocular Surface Disease sales team! Huge thanks to Dr. Bobby Saenz, Stacie Cooley, Michael Canda, and Michael Valenti for leading the training and sharing their expertise on the interventional TearCare therapy.
Welcome to the team, MK Raheja! We are very excited to have MK join Sight Sciences as we continue to transform treatment paradigms with disruptive new eyecare technology and drive our innovation pipeline. MK has more than 35 years of experience in ophthalmology medical device innovation, overseeing global ophthalmic R&D organizations responsible for bringing over 70 ophthalmic innovations to market. Over the past 18 months, MK has been advising emerging ophthalmic companies and not-for-profit entrepreneurial institutions. His most recent corporate roles include Head of Surgical Vision R&D at Johnson & Johnson Vision and Global Head of Corneal & Cataract R&D at Abbott Medical Optics, spanning over a 14-year period, which ended in April 2023. Prior to those roles, he served as Chief Technology Officer for CIBA Vision (a Novartis Company), and as President and Chief Operating Officer of Hill Top Research, a private equity-funded clinical research organization with operations in North America and Europe. MK began his career at Bausch & Lomb in R&D where he held a number of leadership positions, including Vice President, Research Development & Engineering, and Vice President, New Product & New Business Development. MK holds a Ph.D. from the University of Massachusetts and an Executive M.B.A. from Boston University. Read press release for more details: https://lnkd.in/gmeXmj7x #sightsciences #sightsciencesteam #sightsciencesnews
Please join us in welcoming Brenton Taylor as our Executive Vice President of Operations! We are very excited to have Brenton join Sight Sciences as we continue to strengthen our commitment to advancing innovative eyecare solutions and supporting scalable operations and growth. Brenton has nearly 25 years of experience in medical and energy technology development and operations, overseeing innovation, product development, and manufacturing. He most recently served as Chief Executive Officer at NEXT Energy Technologies, a pioneer in organic photovoltaic (OPV) technology, where he initially joined as Executive Vice President, Engineering in 2021. Prior to this role, Mr. Taylor co-founded Inogen, Inc (Nasdaq: INGN) (“Inogen”), a medical technology company offering innovative respiratory products for use in the homecare setting, where he spent over 20 years and was instrumental in developing and scaling a line of innovative respiratory medical devices to $350 million in annual sales. His last role at Inogen was Executive Vice President, Engineering. Brenton received a B.S. in microbiology from the University of California, Santa Barbara. Read more: https://lnkd.in/gmeXmj7x #sightsciences #sightsciencesteam #sightsciencesnews
Our California sales team recently came together for an inspiring two-day pocket meeting—celebrating progress, planning for the future, and giving back to the community. It was a perfect mix of strategy sessions, team-building fun, and collecting donations for the Friends In Deed organization, which supports those in need. Great work, Team California—your dedication inspires us all!
The 'OMNI in Action' program at our #AAO2024 booth was a great success. A round of applause to Zarmeena Vendal, MD, and Matthew Brink, MD, for their insights on interventional glaucoma and for demonstrating the power of OMNI. Thank you to everyone who attended. Stay tuned—the case presentation will soon be available on our YouTube channel!
A few highlights from #AAO2024. Thank you to everyone who visited our booth—we truly appreciated the insightful conversations and the opportunity to connect with so many dedicated professionals in the field of ophthalmology.
Excited to be at #AAO2024 and looking forward to connecting with friends, partners, customers, and colleagues! Visit us at booth 4019 to meet our team and explore our technologies—OMNI, SION, and TearCare!